Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Nuclear receptor ROR-gamma | ||
Ligand | BDBM50112367 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1513553 (CHEMBL3610010) | ||
IC50 | 4.0±n/a nM | ||
Citation | Wang, Y; Cai, W; Cheng, Y; Yang, T; Liu, Q; Zhang, G; Meng, Q; Han, F; Huang, Y; Zhou, L; Xiang, Z; Zhao, YG; Xu, Y; Cheng, Z; Lu, S; Wu, Q; Xiang, JN; Elliott, JD; Leung, S; Ren, F; Lin, X Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant ROR¿t Inhibitors. ACS Med Chem Lett6:787-92 (2015) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Nuclear receptor ROR-gamma | |||
Name: | Nuclear receptor ROR-gamma | ||
Synonyms: | NR1F3 | Nuclear receptor ROR-gamma | Nuclear receptor ROR-gamma (RORC) | Nuclear receptor subfamily 1 group F member 3 | RAR-related orphan receptor C (RORc) | RORC | RORG | RORG_HUMAN | RZRG | Retinoid-related orphan receptor-gamma | Retinoid-related orphan receptor-gamma (RORc) | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 58218.40 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P51449 | ||
Residue: | 518 | ||
Sequence: |
| ||
BDBM50112367 | |||
n/a | |||
Name | BDBM50112367 | ||
Synonyms: | CHEMBL3609407 | ||
Type | Small organic molecule | ||
Emp. Form. | C23H18Cl2F3NO4S | ||
Mol. Mass. | 532.36 | ||
SMILES | CCS(=O)(=O)c1ccc(CC(=O)Nc2cc(Cl)c(c(Cl)c2)-c2ccccc2OC(F)(F)F)cc1 |(-3.74,3.7,;-2.67,3.08,;-2.67,1.54,;-3.73,.92,;-3.74,2.16,;-1.33,.77,;,1.54,;1.33,.77,;1.33,-.77,;2.67,-1.54,;2.66,-3.08,;1.6,-3.7,;4,-3.86,;3.99,-5.4,;5.33,-6.17,;5.32,-7.71,;6.39,-8.33,;3.98,-8.48,;2.65,-7.7,;1.58,-8.32,;2.66,-6.16,;3.98,-10.02,;2.64,-10.78,;2.63,-12.32,;3.96,-13.1,;5.3,-12.34,;5.31,-10.8,;6.65,-10.03,;7.98,-10.81,;9.05,-10.21,;7.97,-12.05,;9.04,-11.44,;,-1.54,;-1.33,-.77,)| | ||
Structure |